Coronary diseaseStructural heart diseasePharmacology

SOLACI-SOCIME 2018 | New Indications

solaci
solaci
543
0

Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress.

See the presentation by Dr. Flavio Ribichini, entitled “New Indications”.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
SOLACI-SOCIME 2018 | When Not to Use a Device: Characteristics of Atrial Septal Defects that Do Not Lead to Percutaneous Closure
Next article
SOLACI-SOCIME 2018 | Retrograde approach: techniques and results
solaci
solaci

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Dr. Juan Manuel Pérez - 0
Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Carotid

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Dr. Juan Manuel Pérez - 0
Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...